---

Cancer Types

Types of Cancer > Urinary Tract Cancers > Kidney Cancer > Conferences

Conferences

OncoLink at ASCO 2009

Final results of the phase III, randomized, double-blind AVOREN trial of first-line bevacizumab (BEV) + interferon-α2a (IFN) in metastatic renal cell carcinoma (mRCC)

OncoLink at ASCO 2008

RAD001 versus placebo in patients with metastatic renal cell carcinoma (RCC) after progression on VEGFr-TKI therapy: Results from a randomized, double-blind, multicenter phase III study

OncoLink at ASCO 2007

A randomized, controlled, double-blind phase III study (AVOREN) of bevacizumab/interferon-a2a vs. placebo/interferon-a2a as first-line therapy in metastatic renal cell carcinoma

OncoLink at ASCO 2006

Outcome of clear cell sarcoma of the kidney (CCSK) treated on the National Wilms Tumor Study-5 (NWTS)

OncoLink at the Chemotherapy Foundation Symposium 2005

Bevacizumab/Erlotinib Combinations in the Treatment of Metastatic Renal Cell Carcinoma (RCC)

OncoLink at ASCO 2005

Randomized phase III trial of the Raf kinase and VEGFR inhibitor sorafenib (BAY 43-9006) in patients with advanced renal cell carcinoma (RCC).

OncoLink at ASCO 2004

Phase II trial of bevacizumab and erlotinib in patients with metastatic renal carcinoma (RCC)

OncoLink at ASH 2002

Zoledronic Acid, Hypocalcemia and Renal Dysfunction in Thalidomide-Treated Myeloma Patients

OncoLink at ASCO 2002

Multicenter Phase III Trial to Compare Radical Nephrectomy Plus Adjuvant Autologous Tumor Cell-Lysate Vaccine Versus Radical Nephrectomy Without Adjuvant Treatment for Renal Cell Carcinoma Stages pT2-3bN0-3M0: a 3-year Analysis

OncoLink at ASCO 2001

A Phase I study of oxaliplatin in cancer patients with impaired renal function

OncoLink at ASCO 2000

Cytoreduction Nephrectomy in Metastatic Renal Cancer: The Results of Southwest Oncology Group Trial 8949

OncoLink at ASCO 1999

First Kidney Cancer Blood Test Could Prevent Removal of Kidneys

OncoLink at ASCO 1998

Chemical Derived from Naturally-Occurring Mold May Slow Growth of Metastatic Kidney Cancer by Inhibiting Growth of Tumor Blood Supply

OncoLink at ASCO 1996

Interferon Plus Chemotherapy Is Better Than Chemotherapy Alone In Renal Cell Cancer